Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting. (8th November 2016)

• Record Type: Journal Article
• Authors: Kumpe, David A; Seinfeld, Joshua; Huang, Xianchen; Mei, Quelin; Case, David E; Roark, Christopher D; Subramanian, Prem S; Lind, Kimberly E; Pelak, Victoria S; Bennett, Jeffrey L
• Is Part Of: Journal of neurointerventional surgery. Volume 9:Number 9(2017)
• Page Start: 867
• Page End: 874
• Publication Date: 2016-11-08
• Subjects: Intervention -- Intracranial Pressure -- Stenosis -- Stent -- Vein; Nervous system -- Surgery -- Periodicals; Cerebrovascular disease -- Surgery -- Periodicals; 617.48
• DOI: 10.1136/neurintsurg-2016-012810
• Languages: English
• ISSNs: 1759-8478

Abstract

Abstract : Background: Some patients undergoing dural sinus stenting for idiopathic intracranial hypertension (IIH) develop clinical and hemodynamic failure (recurrence of the pressure gradient) owing to stent-adjacent stenosis. Objective: To characterize factors associated with hemodynamic failure, and to describe outcomes of patients after repeat stenting. Materials and methods: We reviewed the initial and follow-up clinical, venographic, and hemodynamic data in 39 patients with IIH treated over 17 years with stenting. Thirty-two had follow-up angiographic and hemodynamic data at 1–99 months (mean 27.6, median 19.5 months). Eight patients were treated with 12 repeat stenting procedures, including extended stenting into the superior sagittal sinus (SSS). Results: All patients had an initial successful hemodynamic result with the pressure gradient reduced from 10–43 to 0–7 mm Hg. 10/32 patients (31.3%), all women, developed new stenoses in the transverse sinus or posterior SSS above the stent with a recurrent pressure gradient. 7/9 patients with pure extrinsic stenosis of the transverse-sigmoid junction pre-stenting developed new stenoses and hemodynamic failure. All patients with hemodynamic failure who were restented had early and mid-term documented hemodynamic success at 1.7–50 months. They were free from papilledema at 3.8–50 months after the last restenting, and 11.5–99.5 months after initial stent placement (mean 45.3, median 38.5 months). Conclusions: Pure extrinsic compression of the transverse-sigmoid junction and female gender were strongly associated with hemodynamic failure. Eight patients with hemodynamic failure who were restented had successful control of papilledema, including 4/4 who had extended stenting into the SSS.